ICU sedation, delirium & recovery

Persistent inspiratory muscle weakness among extubated patients after prolonged intubation is frequent and can be predicted early by maximal inspiratory pressure measured 12 days after its initial diagnosis: a prospective observational study

Crit CarePublished Prospective observational study

Authors' conclusion

Persistent IMW following prolonged MV is frequent throughout the acute care stay and until acute care hospital discharge. The MIP measured at day 12 after inclusion, as well as its change from inclusion to day 12, were strongly associated with persistent IMW.

Study context

Population
Intensive Care Unit (ICU) patients extubated after ≥ 7 days of mechanical ventilation (MV) with inspiratory muscle weakness (IMW, Maximal Inspiratory Pressure (MIP) ≤ 30 cmH2O) diagnosed within 48 h post planned extubationcompleted the study
Participants
Sixty-nine patients
Exposure
Persistent IMW vs No persistent IMW
  • Persistent IMWn = 30
Outcome
Persistent IMW (MIP ≤ 30 cmH2O) at end of acute care hospital stay and associated factors
Follow-up
Study completion
Methodological detailsexploratory, multicentre (five Swiss hospitals)
  • Exploratory
  • Multicentre (five Swiss hospitals)

Main finding

As reported in the abstract

Persistent IMW
GroupValueMedian MIP
Persistent IMW43%22 [13-24] cmH2O
No persistent IMWmedian 44 (IQR 36–64)

Value

Persistent IMW43%
No persistent IMWmedian 44 (IQR 36–64)

Median MIP

Persistent IMW22 [13-24] cmH2O
No persistent IMW— not stated in the abstract

Observational data: associations, not effects.

Original publication

Persistent inspiratory muscle weakness among extubated patients after prolonged intubation is frequent and can be predicted early by maximal inspiratory pressure measured 12 days after its initial diagnosis: a prospective observational study. Crit Care. Published 7 November 2025. doi:10.1186/s13054-025-05718-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.